NCT00326092View on ClinicalTrials.gov

A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Open-angle GlaucomaOcular Hypertension
Interventions
DRUG

Brinzolamide/Timolol

Trial Locations (1)

76134

Fort Worth and Other Sites, Fort Worth

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00326092 - A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension | Biotech Hunter | Biotech Hunter